The University reported a total of 105 active COVID-19 cases as of Thursday, an increase of 19 cases since Monday's total of 86 active cases, rising above 100 for the first time since Feb. 25.
Of the cases, 98 are students and seven are faculty and staff, according to the update. There are 86 active cases among off-campus students in the metropolitan Phoenix area, with 12 students in isolation on the Tempe campus. There are no active cases on the Downtown Phoenix, West or Polytechnic campuses.
Since Jan. 1, the University has reported 2,108 cumulative COVID-19 cases out of the more than 83,904 tests administered in that time frame. ASU has had a test positivity rate of roughly 2.5% since Jan. 1.
Students make up 1,779 of those who have tested positive since Jan. 1 and employees account for 329. The total number of cumulative COVID-19 cases since Aug. 1 is 6,616 within the ASU community.
Tuesday, the Centers for Disease Control and Prevention and Federal Drug Administration announced a pause in administering the Johnson & Johnson COVID-19 vaccine due to six reported cases of blood clots out of over 6.8 million vaccines administered to people across the U.S.
ASU in turn has halted the Johnson & Johnson COVID-19 vaccine administration at University vaccine sites temporarily due to the federal announcement.
Joshua LaBaer, executive director of the Biodesign Institute, said in a briefing Wednesday the pause on administering the Johnson & Johnson COVID-19 vaccine in the country should not take too long.
"We all recognize that the risk appears to be very small, you know, less than one in 1,000,000," LaBaer said. "One of the reasons I believe for the pause is to take a moment and look to make sure that there aren't other cases that we have not observed there."
The Arizona Department of Health Services reported 460 new cases and 14 new deaths Thursday. The state reported that just over 2.6 million Arizonans have received at least one dose of the COVID-19 vaccine.
To check appointment availability or to sign up to receive the COVID-19 vaccine, go to the ADHS vaccine patient portal.
Weekend editor Piper Hansen contributed to the reporting of this article.
Reach the reporter at anatar12@asu.edu or follow @AnushaNat1 on Twitter.
Like The State Press on Facebook and follow @statepress on Twitter.
Continue supporting student journalism and donate to The State Press today.
